TriLink - Accelerate mRNA Production with Maximum Efficiency

Category: Cell Therapy and Regenerative Medicine

Booth No: M114

Characteristic

TriLink BioTechnologies is a global leader in RNA technologies, dedicated to providing high-quality synthetic nucleic acid products and mRNA solutions for academic research, biopharmaceutical development, and vaccine innovation. TriLink is renowned for its proprietary CleanCap® co-transcriptional capping technology, which simplifies the conventional enzymatic capping process and significantly improves capping efficiency—enhancing protein expression while minimizing immune responses.

CleanScript™ IVT
To further improve mRNA production efficiency, TriLink has launched the new CleanScript™ IVT Kit combined with the innovative CleanScribe™ Polymerase, enabling the synthesis of high-yield, low-dsRNA mRNA. It is an ideal solution for vaccine development, cancer immunotherapy, and cell therapy applications.

saRNA Product Line
TriLink’s latest self-amplifying RNA (saRNA) products offer low-dose, high-expression, and long-lasting mRNA expression—paving the way for next-generation vaccines and gene therapies. TriLink also provides GMP-grade mRNA, NTPs, and custom nucleic acid materials, fully supporting customers from early-stage research to clinical and commercial-scale production, playing a pivotal role in RNA-based drug and vaccine innovation worldwide.

Custom mRNA Services
TriLink’s expanded custom mRNA synthesis services are designed to meet your specific needs across various stages of application and development. Whether you are at the screening, hit-to-lead optimization, or preclinical stage, we have the right format and yield for your mRNA projects.

Other Popular Products
✓ CleanCap® mRNA capping reagents
✓ Catalog mRNA products
✓ IVT enzymes

Integrated Bio is the exclusive distributor of TriLink BioTechnologies in Taiwan. Only we can offer you the most complete support and product information available!